CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- PositionOperating margin is -114.4%, lower than 95% of its Medical Devices peers (median 7.3%)
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
503.55MUSDvs all stocks (USD)
Revenue (TTM)
159.27MUSDvs all stocks (USD)
Profit Margin
-82.49%vs Medical Devices peers
Beta
2.31xvs all stocks
52-Week Change
29.60%vs all stocks
Market Capitalization
503.55MUSDvs all stocks (USD)
Enterprise Value
975.80MUSDvs all stocks (USD)
Forward P/E
-4.03xvs Medical Devices peers
Price to Sales (TTM)
3.16xvs Medical Devices peers
Enterprise to Revenue
6.13xvs Medical Devices peers
Enterprise to EBITDA
4.90xvs Medical Devices peers
Gross Margin
32.40%vs Medical Devices peers
Profit Margin
-82.49%vs Medical Devices peers
Operating Margin
-114.36%vs Medical Devices peers
Return on Assets (TTM)
-14.07%vs Medical Devices peers
Revenue (TTM)
159.27MUSDvs all stocks (USD)
Revenue per Share (TTM)
0.5230USDUpdated Sep 28, 2026Quarterly Revenue Growth
-1.90%vs Medical Devices peers
Gross Profit (TTM)
46.86MUSDvs all stocks (USD)
EBITDA (TTM)
199.18MUSDvs all stocks (USD)
Net Income (TTM)
-131.39MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
-1.91%vs Medical Devices peers
Operating Cash Flow (TTM)
-118.05MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Sep 28, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Devices peers
Revenue
160.00MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
114.22MUSDFY2025 · Dec 31, 2025Gross Profit
45.78MUSDFY2025 · Dec 31, 2025Operating Income
-557.56MUSDvs all stocks (USD)
Pre-tax Income
-546.06MUSDFY2025 · Dec 31, 2025Income Tax Expense
318.00KUSDFY2025 · Dec 31, 2025Net Income
-546.38MUSDFY2025 · Dec 31, 2025EBIT
-539.10MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-156.39MUSDFY2025 · Dec 31, 2025Research & Development
97.31MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
141.49MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
6.95MUSDFY2025 · Dec 31, 2025EPS (Basic)
-1.82USDFY2025 · Dec 31, 2025EPS (Diluted)
-1.82USDFY2025 · Dec 31, 2025Basic Shares Outstanding
299.96MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
299.96MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-546.38MUSDFY2025 · Dec 31, 2025Operating Cash Flow
-143.08MUSDFY2025 · Dec 31, 2025Free Cash Flow
-145.80MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
65.26MUSDFY2025 · Dec 31, 2025Interest Paid
8.26MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-546.38MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
386.41MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
-546.00KUSDFY2025 · Dec 31, 2025Stock-based Compensation
41.67MUSDFY2025 · Dec 31, 2025Other Non-cash Items
-17.01MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-7.92MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
2.48MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-1.79MUSDFY2025 · Dec 31, 2025Capital Expenditures
-2.71MUSDFY2025 · Dec 31, 2025Net Intangibles (CF)
-5.00MUSDFY2025 · Dec 31, 2025Net Acquisitions
0.00USDFY2025 · Dec 31, 2025Purchase of Investments
-216.91MUSDFY2025 · Dec 31, 2025Sale of Investments
340.07MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
120.45MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
0.00USDFY2025 · Dec 31, 2025Net Financing Cash Flow
0.00USDFY2025 · Dec 31, 2025Shares Outstanding
310.81MSharesUpdated Sep 28, 2026Float Shares
304.01MSharesUpdated Sep 28, 2026Shares Short
48.89MSharesUpdated Sep 28, 2026Short Ratio
8.02daysvs all stocks
Short % of Shares Outstanding
18.08%vs all stocks
% Held by Insiders
8.91%vs all stocks
% Held by Institutions
55.52%vs all stocks
Total Cash (MRQ)
236.87MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.7620USDUpdated Sep 28, 2026Total Debt (MRQ)
709.13MUSDvs all stocks (USD)
Current Ratio (MRQ)
4.92xvs Medical Devices peers
Book Value per Share (MRQ)
-0.1070USDUpdated Sep 28, 2026Total Assets
784.08MUSDvs all stocks (USD)
Total Current Assets
375.05MUSDFY2025 · Dec 31, 2025Total Liabilities
778.73MUSDFY2025 · Dec 31, 2025Total Non-current Assets
409.03MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
705.90MUSDFY2025 · Dec 31, 2025Total Current Liabilities
72.83MUSDFY2025 · Dec 31, 2025Cash
60.50MUSDFY2025 · Dec 31, 2025Cash Equivalents
3.21MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
63.71MUSDFY2025 · Dec 31, 2025Other Short-term Investments
215.80MUSDFY2025 · Dec 31, 2025Accounts Receivable
35.45MUSDFY2025 · Dec 31, 2025Inventory
49.28MUSDFY2025 · Dec 31, 2025Accounts Payable
20.77MUSDFY2025 · Dec 31, 2025Short-term Debt
448.00KUSDFY2025 · Dec 31, 2025Deferred Revenue
15.94MUSDFY2025 · Dec 31, 2025Other Current Liabilities
654.00KUSDFY2025 · Dec 31, 2025Long-term Debt
701.97MUSDFY2025 · Dec 31, 2025Common Stock (Book)
302.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-2.70BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
5.35MUSDvs all stocks (USD)
52-Week Low
1.07USDUpdated Sep 28, 202652-Week High
2.73USDUpdated Sep 28, 202652-Week Change
29.60%vs all stocks
Beta
2.31xvs all stocks
50-Day MA
1.34USDUpdated Sep 28, 2026200-Day MA
1.58USDUpdated Sep 28, 2026Avg 10-Day Volume
6.85MSharesUpdated Sep 28, 2026Avg 30-Day Volume
6.34MSharesUpdated Sep 28, 2026Diluted EPS (TTM)
-0.4200USDUpdated Sep 28, 2026Other Income / Expense
18.46MUSDFY2025 · Dec 31, 20251 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company growing?
Diagnostic
High R&D Share With Multi-Year Share-Count Growth and Elevated SBC
Heavy R&D and stock pay, with the share count growing across six years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is -114.4%, lower than 95% of its Medical Devices peers (median 7.3%)Significant
Operating margin: -1.14Industry median: 0.07Industry P5: -0.73Peers compared: 102
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Boryung Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Puma Biotechnology Inc.
Tier 1ProductionApproval-Gated PipelineRule
Jiangsu Bioperfectus Technologies Co., Ltd.
Tier 1ProductionApproval-Gated PipelineFlowRule
Ever Supreme Bio Technology Co., Ltd
Tier 1ProductionApproval-Gated PipelineRuleFlow
Bright Minds Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Ningbo David Medical Device Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Beijing Succeeder Technology Inc.
Tier 1ProductionApproval-Gated PipelineRule
Hinova Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Jiangsu Hanbon Science & Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Onconic Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
ImmunityBio, Inc.
1 interpretationHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBC
Iovance Biotherapeutics, Inc.
1 interpretationHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBC
AbCellera Biologics Inc.
1 interpretationHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBC